Upload
shemin-mehta
View
228
Download
0
Embed Size (px)
Citation preview
8/2/2019 Chuppa Rustom PET and Dementias
1/18
Chuppa Rustom PET and
Dementias
Dr. Shemin Mehta
3rd year DNB RadiologyDr. Balabhai Nanavati Hospital
8/2/2019 Chuppa Rustom PET and Dementias
2/18
Dementia The Indian Perspective
In 2010, there are 3.7 million Indians withdementia and the total societal cost isabout 14,700 crore
The cost of taking care of a person withdementia is about Rs. 43,000/- annually
While the numbers are expected to double
by 2030, costs would increase three times Early detection allows early initiation of
therapy to slow decline
8/2/2019 Chuppa Rustom PET and Dementias
3/18
Diagnosis
Dementia diagnosis is essentially clinical falsenegative in 50-90%
Laboratory investigations play a supportive role
Structural imaging in the form of CT and MRI isinadequate in early stages, as well as havinglow sensitivity and specificity
Functional imaging, i.e. PET is more sensitiveand allows further disease characterization
8/2/2019 Chuppa Rustom PET and Dementias
4/18
When to conduct a dementiaevaluation
Patient/family concerns
Functional impairment (driving, self-care)
Changes in personality & behaviour
Persistent cognitive deficit after deliriumclears
Abrupt change in cognitive, emotional or
neurologic status Depression associated with reversible
dementia (50% irreversible after 5 years)
8/2/2019 Chuppa Rustom PET and Dementias
5/18
Patterns
Alzheimers Disease posterior cingulate,parietal and temporal cortices frontalinvolvement as AD progresses
Frontotemporal Dementia frontotemporal
abnormality with preserved posteriorfunctioning D/D from AD
Vascular Dementia patchy hypometabolicpattern in cortical & subcorticalregions
Dementia with Lewy Bodies parietal, temporaldeficits with frontal involvement as diseaseprogresses (similar to AD) along with occipitalhypometabolism
8/2/2019 Chuppa Rustom PET and Dementias
6/18
Case 1
70/M
C/o forgetfulness,decreasedcomprehension, lack of
responsiveness
Insidious onset ofsymptoms
CT - Moderate cerebralatrophy, prominence ofsylvian fissures
8/2/2019 Chuppa Rustom PET and Dementias
7/18
MRI and MRS
Multiple bilaterallacunar infarcts
Mild cerebral and
cerebellar atrophy Periventricular white
matter ischemia
MRS reduced NAA,mI and Chometabolic disorder
8/2/2019 Chuppa Rustom PET and Dementias
8/18
PET-CT findings, Evaluation withScenium
Hypometabolismbilateral temporo-parietal, frontal
regions, bothhippocampi,amygdala, mesialtemporal lobe
Occipital regionslargely unaffected
Alzheimers disease
8/2/2019 Chuppa Rustom PET and Dementias
9/18
Case 2
77/M
H/o socialdisinhibition,
aggressiveness CT moderate
atrophic changes,mild periventricularischemia
8/2/2019 Chuppa Rustom PET and Dementias
10/18
PET-CT findings, Evaluation withScenium
Frontotemporal deficit
Preserved posteriorfunctioning
Frontotemporaldementia (FTD)
8/2/2019 Chuppa Rustom PET and Dementias
11/18
Case 3
61/F
C/o decreased
attention and
decreased cognition CT temporoparietal
atrophy, moderateperiventricularischemia
8/2/2019 Chuppa Rustom PET and Dementias
12/18
PET-CT findings, Evaluation withScenium
Parietal and temporaldeficits
Marked occipitalhypometabolism
Preserved frontalmetabolism
Lewy Body Dementia
8/2/2019 Chuppa Rustom PET and Dementias
13/18
PET Present Status
Adds to clinical picture improves diagnosticaccuracy
Dementia diagnosis sensitivity with PET 91.5
+/- 3.5%, sensitivity without PET 66 +/- 17% To differentiate AD from FTD
Early identification of patients who will developAD and other dementias
Sensitive to AD-like hypometabolic changes innon-dementedpersons with APOE-4 risk forAD
8/2/2019 Chuppa Rustom PET and Dementias
14/18
PET Present Status
Predicts cognitive decline in patients with APOE-4, normal elderly and persons with mild memoryimpairment
Predicts progression from Mild CognitiveImpairment (MCI) to dementia
Sensitive to preclinicalcognitive changes inpatients with high cognitive reserve
Normal study reassures worried well Role in Age-Associated Memory Impairment
(AAMI)
8/2/2019 Chuppa Rustom PET and Dementias
15/18
Future Trends
F18-FDDNP tovisualise neurofibrillarytangles and senileplaques in AD; amyloid
labelling to followneuropathologic evolutionof AD in living subjects
F18-MPPF selectiveprobe for serotonin 1A
receptors as an index ofhippocampal neuronalloss early detection andmonitoring of dementias
8/2/2019 Chuppa Rustom PET and Dementias
16/18
Future Trends
Newer compoundslike F18-FDOPA andothers to study
dopamine synthesis,dopamine transporterand vesiculartransporter in
Parkinsons disease
8/2/2019 Chuppa Rustom PET and Dementias
17/18
Future Trends
C11-PK11195 aperipheral BZDreceptor agent
shows increaseduptake in AD, PD,multisystem atrophy,MND may correlate
with disease severityand mark diseaseonset
8/2/2019 Chuppa Rustom PET and Dementias
18/18
References
PET in the Evaluation of Alzheimers
Disease and Related Disorders DanielSilverman
The Dementia India Report 2010